The Cardiovascular Disease (CVD) and Diabetes Screening Program offers a screening, including a blood pressure reading and lipid panel. All participants receive a risk profile letter that outlines their results.

Phase 1: Cardiovascular Disease (CVD) and Diabetes Screening

The purpose of the CVD screening is to identify employees at varying levels of risk for CVD. CVD risk screenings are available for all KSC and CCAFS employees and will be announced in the KSC Daily News & NASA Community. Parameters measured include exercise frequency, blood pressure, weight, height, body mass index, total cholesterol (including HDL and LDL cholesterol) and triglycerides. The Diabetes Screening is offered through an A1C test for employees who select to have it. It is recommended participants complete questionnaires prior to the screening. It is also recommended participants fast for 12 hours prior, but it is not required and participants should consult their primary care provider, prior to fasting, if diabetic.

2024 CVD and Diabetes Screening Schedule 

OHF – Occupational Health Facility (M6-495, KSC Industrial Area)

Date	Place	Time
February 6, 2024	OHF	7:30 – 9:00 am
May 21, 2024	OHF	7:30 – 9:00 am
August 6, 2024	OHF	1:00-2:30 pm

The 2-page CVD and Diabetes Screening Program, Form Number 28-1010 in NASA Electronic Forms (NEF), can be picked up at the OHF, KSC Fitness Center, or if you have access to NASA SharePoint, download HERE. Please complete the 2 pages on separate sheets, and bring them with you the day of your screening.

Phase 2: CVD Risk Follow Up

The purpose of this phase is to educate employees concerning their CVD risk. CVD education is provided through both the risk profile letter, and with additional resources for high risk employees, which is included with their letter.